Device Trial Radar · NCT05540457
Evaluation of Non-Invasive Continuous vs Intermittent BloodPressure Monitors in Maintenance Dialysis (BP Dialysis)
Last checked: Nov 20, 2026Latest source record: Jun 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
10
Actual
Start
Sep 22, 2022
Primary completion
Feb 9, 2024
Study completion Feb 9, 2024
Sponsor
- Lead sponsor
- The Rogosin InstituteAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Outset Medical; CareTaker Medical LLC
- First posted
- Sep 14, 2022
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Prospective, single center, open label, non-randomized, post-market study of the Tablo Hemodialysis System and VitalStream Monitor in participants with End-Stage KidneyDisease undergoing In-Center Hemodialysis.
Conditions
- End Stage Renal Disease
- End Stage Renal Disease on Dialysis
- Dialysis Hypotension
- Dialysis Induced Hypertension
Interventions
Intermittent Non-InvasiveBlood Pressure MonitorDevice
Brachial cuff integrated with theTablo Hemodialysis System. Cuffwill be placed contralateral to theaccess arm, with measurementscollected pre-dialysis, every 30minutes during dialysis, and post-dialysis. Device: Continuous Non-InvasiveBlood Pressure Monitor VitalStream Monitor. Finger cuffwill be placed ipsilateral to theaccess arm, with measurementscollected pre-dialysis,continuously during dialysis, andpost-dialysis.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Non-invasive Blood Pressure Monitor (NIPB) MeasurementsTime frame: 7 days from start of participation
Locations
1 site in 1 country. Site status is shown where the registry gives one.
The Rogosin Institute
New York, New York
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.